NEW YORK, July 16 - Wyeth-Ayerst Laboratories has extended its genomics research collaboration with Genome Therapeutics for at least an additional 18 months, Genome Therapeutics said Monday. 

The joint research project, to develop osteoporosis treatments using targets found by characterizing a gene associated with high bone mass, will now continue until at least December 2002. Genome Therapeutics recently received a milestone payment from Wyeth-Ayerst for its research progress, the company said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.